Articles by James Calloway
Adobe Stock Tumbles Ahead of Q2 Earnings as AI Monetization and CEO Succession Weigh
Adobe shares dropped 2.7% to $251.44 on Friday, nearing a 40% decline from their 52-week high, as investors brace for fiscal Q2 results on June 11 amid AI monetization concerns and rising competition.
Medtronic Stock Edges Up on Earnings Beat, Tariff Warning Looms
Medtronic shares slipped 0.32% to $81.67 Friday after a post-earnings rally, as strong Q4 revenue growth and a dividend hike were offset by a $250 million tariff hit and profit guidance below consensus.
Accenture Shares Slide Ahead of Q3 Earnings Amid AI Deals and Market Headwinds
Accenture shares dropped 4.7% to $178.25 ahead of its June 18 earnings call, as AI deals and a Japan partnership compete with market losses and tech spending concerns.
Campbell Soup Set for S&P 500 Exit Ahead of Weak Earnings Report
Campbell Soup (CPB) exits the S&P 500 on June 22, moving to the SmallCap 600, as analysts forecast lower Q3 sales and earnings. The stock rose 2.7% last week despite broader market losses.
Accenture Shares Swing Wildly Ahead of Q3 Earnings Report
Accenture shares fell 4.7% this week to $178.25 as investors await June 18 Q3 results, with focus on bookings and AI demand after record $22.1 billion Q2 bookings.
Cooper Companies Surges 8.6% Despite Broader Market Selloff, Strategic Review in Focus
Cooper Companies rose 8.6% on Friday to $67.34, outperforming a sharp market decline, as investors focused on better-than-expected quarterly profit and the ongoing strategic review of its CooperSurgical unit.
Paramount-Warner Merger Faces State Lawsuit Threat, WBD Shares Drop
Warner Bros. Discovery shares fell 3.6% on reports that states plan to sue to block the Paramount Skydance deal, widening the discount to the $31 cash offer.
TerraVest Plunges 30% on Insider-Tipping Probe
TerraVest shares plunged over 30% after the board launched a review into allegations that Executive Chairman Charles Pellerin shared privileged information before the EnTrans deal.
BioCardia Surges on FDA Minutes Showing CardiAMP Trial Can Support PMA
BioCardia shares surged 52% to $1.40 after FDA meeting minutes confirmed its CardiAMP HF II trial may support a PMA for heart-failure cell therapy, bucking a weak biotech sector.
Costco Gas Sales Surge 14.5% in May, Membership Fee Remains Key
Costco reported a 14.5% sales surge in May, driven by booming gasoline sales and higher prices. Net sales reached $24.01 billion, with shares climbing $16.40 to $988.75.
Pennsylvania Bill Targets Data Centers as Electricity Prices Surge
Pennsylvania House Republicans propose forcing large data centers to secure their own power and pay grid costs after electricity prices jumped statewide June 1.
Lululemon Plunges 12% Premarket on Weak Forecast, North American Woes
Lululemon shares dropped 12% premarket after cutting its annual profit forecast and issuing a weak Q2 outlook, as North American demand falters and margins shrink.